WAYS OF MENOPAUSAL HORMONAL THERAPY IN CORRECTION OF METABOLIC DISORDERS AND ANGIOPROTECTION IN POSTMENOPAUSAL WOMEN

Aim. To compare effectiveness of non-drug therapy together with menopausal hormonal therapy (MHT) — estradiol hemihydrate 1 mg/drospirenon 2 mg (Angeliq® Bayer Pharma AG (Germany)) related to normalization of anthropometric and metabolic parameters, elasticity values and vascular age in women with m...

Full description

Bibliographic Details
Main Authors: V. Yu. Khripaeva, I. N. Barykina, A. S. Salasyuk, V. O. Smirnova, R. V. Palashkin, S. V. Nedogoda
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2016-04-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/706